Mohammad Amin Elahi Najafi
Overview
Explore the profile of Mohammad Amin Elahi Najafi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
7
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tatenuma T, Matsukawa T, Goto T, Jiang G, Sharma A, Najafi M, et al.
Cancer Genomics Proteomics
. 2024 Oct;
21(6):557-565.
PMID: 39467629
Background/aim: Precise molecular mechanisms underlying resistance to cisplatin-based chemotherapy remain unclear, while the activity of estrogen receptor-β (ERβ) has been suggested to be associated with chemosensitivity in urothelial cancer. We...
2.
Teramoto Y, Yang Z, Matsukawa T, Najafi M, Goto T, Miyamoto H
Am J Cancer Res
. 2024 Oct;
14(9):4367-4377.
PMID: 39417173
PPARγ coactivator-1α (PGC1α), as a co-activator, is known to optimize the action of several transcription factors, including androgen receptor (AR). However, the precise functions of PGC1α in prostate cancer, particularly...
3.
Ahmadi S, Bagherzadeh O, Sargazi M, Kalantar F, Najafi M, Vahedi M, et al.
Biofactors
. 2024 Aug;
51(1):e2115.
PMID: 39189819
Neuroblastomas are the most common solid tumors outside of the brain that originate from immature neural crest cells, accounting for about 10% of all pediatric malignancies. The treatment for neuroblastomas...
4.
Teramoto Y, Najafi M, Matsukawa T, Sharma A, Goto T, Miyamoto H
Int J Mol Sci
. 2024 Jul;
25(13).
PMID: 39000396
Latrophilins (LPHNs), a group of the G-protein-coupled receptor to which a spider venom latrotoxin (LTX) is known to bind, remain largely uncharacterized in neoplastic diseases. In the present study, we...
5.
Najafi M, Yasui M, Teramoto Y, Tatenuma T, Jiang G, Miyamoto H
Int J Mol Sci
. 2023 Sep;
24(18).
PMID: 37762034
The precise molecular mechanisms responsible for resistance to cisplatin-based chemotherapy in patients with bladder cancer remain elusive, while we have indicated that androgen receptor (AR) activity in urothelial cancer is...
6.
Salimi S, Honar B, Tajbakhsh A, Memary E, Mirkheshti A, Najafi M
Med J Islam Repub Iran
. 2022 Sep;
36:47.
PMID: 36128289
Low pressure laparoscopic cholecystectomy has been advocated due to reduction in postoperative pain, ventilation problems, hemodynamic complications, and potential for reduction in surgical events. No reported data have been found...